|
1
|
Steiner AL, Goodman AD and Powers SR:
Study of a kindred with pheochromocytoma, medullary thyroid
carcinoma, hyperparathyroidism and Cushing's disease: Multiple
endocrine neoplasia, type 2. Medicine (Baltimore). 47:371–409.
1968. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farndon JR, Leight GS, Dilley WG, Baylin
SB, Smallridge RC, Harrison TS and Wells SA: Familial medullary
thyroid carcinoma without associated endocrinopathies: A distinct
clinical entity. Br J Surg. 73:278–281. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ezzat T, Paramesawaran R, Phillips B and
Sadler G: MEN 2 syndrome masquerading as MEN 1. Ann R Coll Surg
Engl. 94:e206–e207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muzannara MA, Tawfeeq N, Nasir M, Al Harbi
MK, Geldhof G and Dimitriou V: Vaginal delivery in a patient with
pheochromocytoma, medullary thyroid cancer, and primary
hyperparathyroidism (multiple endocrine neoplasia type 2A, Sipple's
syndrome). Saudi J Anaesth. 8:437–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lau GS, Lang BH, Lo CY, Tso A,
Garcia-Barcelo MM, Tam PK and Lam KS: Prophylactic thyroidectomy in
ethnic Chinese patients with multiple endocrine neoplasia type 2A
syndrome after the introduction of genetic testing. Hong Kong Med
J. 15:326–331. 2009.PubMed/NCBI
|
|
6
|
American Thyroid Association Guidelines
Task Force. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib
H, Moley JF, Pacini F, Ringel MD, Schlumberger M and Wells SA Jr:
Medullary thyroid cancer: Management guidelines of the American
Thyroid Association. Thyroid. 19:565–612. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brandi ML, Gagel RF, Angeli A, Bilezikian
JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG,
Libroia A, et al: Guidelines for diagnosis and therapy of MEN type
1 and type 2. J Clin Endocrinol Metab. 86:5658–5671. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moley JF: The molecular genetics of
multiple endocrine neoplasia type 2A and related syndromes. Annu
Rev Med. 48:409–420. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Imai T, Uchino S, Okamoto T, Suzuki S,
Kosugi S, Kikumori T and Sakurai A: MEN Consortium of Japan: High
penetrance of pheochromocytoma in multiple endocrine neoplasia 2
caused by germ line RET codon 634 mutation in Japanese patients.
Eur J endocrinol. 168:683–687. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rowland KJ, Chernock RD and Moley JF:
Pheochromocytoma in an 8-year-old patient with multiple endocrine
neoplasia type 2A: Implications for screening. J Surg Oncol.
108:203–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krampitz GW and Norton JA: RET gene
mutations (genotype and phenotype) of multiple endocrine neoplasia
type 2 and familial medullary thyroid carcinoma. Cancer.
120:1920–1931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mulligan LM, Kwok JB, Healey CS, Elsdon
MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, et al:
Germ-line mutations of the RET proto-oncogene in multiple endocrine
neoplasia type 2A. Nature. 363:458–460. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mathew CG, Smith BA, Thorpe K, Wong Z,
Royle NJ, Jeffreys AJ and Ponder BA: Deletion of genes on
chromosome 1 in endocrine neoplasia. Nature. 328:524–526. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tessitore A, Sinisi AA, Pasquali D,
Cardone M, Vitale D, Bellastella A and Colantuoni V: A novel case
of multiple endocrine neoplasia type 2A associated with two de novo
mutations of the RET protooncogene. J Clin Endocrinol Metab.
84:3522–3527. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qi X-P, Ma J-M, Du Z-F, Ying R-B, Fei J,
Jin HY, Han JS, Wang JQ, Chen XL, Chen CY, et al: RET germline
mutations identified by exome sequencing in a Chinese multiple
endocrine neoplasia type 2A/familial medullary thyroid carcinoma
family. PLoS One. 6:e203532011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gosnell JE, Sywak MS, Sidhu SB, Gough IR,
Learoyd DL, Robinson BG and Delbridge LW: New era: Prophylactic
surgery for patients with multiple endocrine neoplasia-2a. ANZ J
Surg. 76:586–590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balachandran K, Kamalanathan S,
Gopalakrishnan S and Murugananadham K: Multiple endocrine neoplasia
2B: Delayed presentation, rapid diagnosis. BMJ Case Rep.
2013:bcr20130091852013.PubMed/NCBI
|
|
18
|
Cui Q, Wang W, Fu Z, Shao X, Zhang Z,
Zhang M, Ju X, Wang K, Chen J and Zhou H: Integrated
DNA-based/biochemical screening for early diagnosis of multiple
endocrine neoplasia type 2A (MEN2A). J Biomed Res. 27:145–150.
2013. View Article : Google Scholar : PubMed/NCBI
|
